Espindolol

N/A

Report date: 2025/06/09 16:50:45
NME

Base Information

Drug NameEspindolol
Drug Alias NameS-pindololS-pindolol benzoateMT-102AGI-001ACM-001.1 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonistsBeta-2 adrenergic receptor agonistsSerotonin 1a (5-HT1a) receptor antagonists
TargetsBeta-1 adrenergic receptorBeta-2 adrenergic receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsCachexiaObesitySarcopenia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSerbiaGermany +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAkamis Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMankind Pharma LtdActimed Therapeutics Ltd
Inactive CompaniesAkamis Bio Ltd
Active IndicationsCachexiaObesitySarcopenia +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A